Pharma Journalist 7836 posts 0 comments

ANI Pharmaceuticals, Inc. announced that it has acquired Inderal XL from Cranford Pharmaceuticals, LLC and InnoPran XL  from Holmdel Pharmaceuticals LP. The acquired assets include the…
Read More...

Swiss drugmaker Novartis's drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lung cancer after a key committee on Friday published a…
Read More...

Cyclacel Pharmaceuticals Inc said its lead experimental drug did not help elderly patients with acute myeloid leukemia live longer in a late-stage study. The drug developer's stock…
Read More...

Finch Therapeutics, Inc., a microbiome therapeutics company, and OpenBiome, a leading public stool bank announced a collaboration to develop FIN-403, an orally administered microbial…
Read More...

Santen, Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., the specialty ophthalmology company headquartered in Osaka, Japan, and twoXAR, Inc., an artificial…
Read More...

Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), today announced that it has entered into a collaboration with Frenova Renal…
Read More...

Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today…
Read More...

AMRI announced that it has entered into an agreement with the pharmaceutical group Ferrer  and Accord Healthcare, Inc. ("Accord Healthcare") to jointly develop and manufacture an…
Read More...

Amphastar Pharmaceuticals Inc said on Tuesday that the U.S. Food and Drug Administration had rejected its application to market an intranasal version of the emergency opioid-overdose…
Read More...

Valeant Pharmaceuticals International, Inc. and EyeGate Pharmaceuticals, Inc., a specialty pharmaceutical company that focuses on developing and commercializing products for treating…
Read More...